Characterization of single microvesicles in plasma from glioblastoma patients

Kyle Fraser1, Ala Jo1, Jimmy Giedt1

  • 1Center for Systems Biology, Massachusetts General Hospital Research Institute, Boston, Massachusetts.

Neuro-Oncology
|December 19, 2018
PubMed
Abstract

Insights

Single microvesicle (MV) analysis reveals extensive heterogeneity in glioblastoma (GB) cell-derived extracellular vesicles (EV). This technique is crucial for identifying rare tumor-derived MV populations for cancer diagnostics.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Extracellular vesicles (EVs) are shed by tumor cells, but their molecular phenotypes and heterogeneity remain poorly understood.
  • While exosomes have been extensively studied, larger microvesicles (MVs) are less characterized.
  • This study focuses on profiling single MVs and exosomes from glioblastoma (GB) cells and MVs from patient plasma.

Purpose of the Study:

  • To investigate the molecular phenotypes and heterogeneity of single microvesicles (MVs) and exosomes from glioblastoma (GB) cells.
  • To analyze MVs from the plasma of GB patients and healthy controls.
  • To assess the utility of single EV analysis for cancer diagnostics.

Main Methods:

  • EVs were isolated from mouse glioma GL261 and human primary GBM8 cell lines, as well as from the plasma of GB patients and healthy controls.
  • Single vesicle analysis was performed by immobilizing EVs on glass slides.
  • Heterogeneity of vesicle and tumor markers was analyzed at the single vesicle level using capture and staining techniques.

Main Results:

  • Microvesicles (MVs) are abundant, but only a minority express putative MV markers.
  • MVs share tetraspanin biomarkers previously considered specific to exosomes.
  • Tumoral MVs constitute less than 10% of total MVs in GB patient plasma, exhibiting significant heterogeneity in tumor marker expression.

Conclusions:

  • Single MV analysis is essential for identifying rare tumoral MV populations.
  • The single vesicle analytical technique is applicable to both MV and exosome fractions without prior separation.
  • These findings establish a foundation for utilizing single EV analyses in cancer diagnostics.

Related Concept Videos

Composition of Blood Plasma01:24

Composition of Blood Plasma

Blood plasma is a fluid that contains approximately 92% water and 8% solutes. The solutes include various types of proteins, which constitute about 7% of the total solutes in the plasma. The high-molecular-weight proteins—albumins, globulins, and fibrinogen—are essential to plasma function. Albumins, making up about 60% of the plasma proteins, maintain the osmotic balance within blood vessels by preventing excessive water leakage. Additionally, albumins serve as carrier proteins,...
8.4K
Enlargement of the Plasma Membrane01:22

Enlargement of the Plasma Membrane

Cell division and enlargement are processes that require precise control. The control ensures that cell division cannot proceed unless the cell has grown to a specific size. A spherical, dividing cell requires an approximately 1.6X increase in its surface area to double its volume. The secretory pathway also has a significant role in cell membrane enlargement. Secretory vesicles that bud off from the Golgi apparatus and later fuse with the plasma membrane during exocytosis are a major source of...
2.4K
Plasma Membrane in Bacteria and Archaea01:27

Plasma Membrane in Bacteria and Archaea

The plasma membrane is an essential cellular structure responsible for maintaining cellular integrity and regulating the selective transport of molecules. While bacteria and archaea share the fundamental function of plasma membranes, their structural and molecular differences reflect adaptations to distinct ecological and physiological challenges.Bacterial Plasma MembranesBacterial plasma membranes are predominantly composed of phospholipids with fatty acid chains ester-linked to a glycerol...
1.8K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K
Protein Buffers in Blood Plasma and Cells01:20

Protein Buffers in Blood Plasma and Cells

The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
3.8K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
18.9K